Quantcast

Latest Amnion Stories

2014-04-29 16:32:03

Company Amends its Patent Infringement Lawsuit to Include Two Additional Patents MARIETTA, Ga., April 29, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its receipt of four newly issued patents related to the Company's tissue allografts derived from the placenta. On April 22, 2014, the U.S. Patent and...

2014-04-28 12:30:43

EDISON, N.J., April 28, 2014 /PRNewswire/ -- The Musculoskeletal Transplant Foundation (MTF) has been notified that on April 21, 2014, MiMedx Group, Inc. (MiMedx) filed a complaint in the United States District Court for the Northern District of Georgia, naming MTF, together with Liventa Bioscience, Inc. and Medline Industries Inc., as defendants. The complaint alleges patent infringement by MTF of four MiMedx patents. MTF does not believe it infringes any of the patents and is...

2014-04-23 12:29:55

EpiFix® is shown to promote rapid healing and return to function for patients and provide a potential for significant cost savings. MARIETTA, Ga., April 23, 2014 /PRNewswire/ -- EpiFix®, dehydrated human amnion/chorion membrane (dHACM) allografts, were shown to be clinically and cost effective in the treatment of multiple hard-to-treat wounds like diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), and pressure ulcers (PUs), according to data and case experiences being presented at the...

2014-04-22 08:33:34

MARIETTA, Ga., April 22, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has filed a patent infringement lawsuit against Liventa Bioscience, Inc. ("Liventa"), Medline Industries, Inc. ("Medline") and Musculoskeletal Transplant Foundation, Inc. ("MTF") for permanent injunctive relief and unspecified...

2009-11-23 15:15:49

For the first time, scientists have demonstrated that stem cells found in amniotic fluid meet an important test of potential to become specialized cell types, which suggests they may be useful for treating a wider array of diseases and conditions than scientists originally thought. Reporting in Oncogene, a publication of Nature Publishing Group, the research teams of Anthony Atala, M.D., director of the Wake Forest Institute for Regenerative Medicine, and Markus Hengstchläger, Ph.D.,...

2005-08-05 08:31:23

By Maggie Fox, Health and Science Correspondent WASHINGTON (Reuters) - Scientists looking for easier and less-controversial alternatives to stem cells from human embryos said on Friday they found a potential source in placentas saved during childbirth. They described primitive cells found in a part of the placenta called the amnion, which they coaxed into forming a variety of cell types and which look very similar to sought-after embryonic stem cells. With 4 million children born in the...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related